Titre : Bloqueurs de canaux sodiques voltage-dépendants

Bloqueurs de canaux sodiques voltage-dépendants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Peru
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Bloqueurs de canaux sodiques voltage-dépendants : Questions médicales les plus fréquentes", "headline": "Bloqueurs de canaux sodiques voltage-dépendants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Bloqueurs de canaux sodiques voltage-dépendants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-25", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Bloqueurs de canaux sodiques voltage-dépendants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Bloqueurs de canaux sodiques", "url": "https://questionsmedicales.fr/mesh/D026941", "about": { "@type": "MedicalCondition", "name": "Bloqueurs de canaux sodiques", "code": { "@type": "MedicalCode", "code": "D026941", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.411.720" } } }, "about": { "@type": "MedicalCondition", "name": "Bloqueurs de canaux sodiques voltage-dépendants", "alternateName": "Voltage-Gated Sodium Channel Blockers", "code": { "@type": "MedicalCode", "code": "D061567", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "William A Catterall", "url": "https://questionsmedicales.fr/author/William%20A%20Catterall", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, University of Washington, Seattle, WA 98195, USA. Electronic address: wcatt@uw.edu." } }, { "@type": "Person", "name": "Piyasuda Pukkanasut", "url": "https://questionsmedicales.fr/author/Piyasuda%20Pukkanasut", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Alabama at Birmingham, Birmingham, AL 35294, USA." } }, { "@type": "Person", "name": "Sadanandan E Velu", "url": "https://questionsmedicales.fr/author/Sadanandan%20E%20Velu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Alabama at Birmingham, Birmingham, AL 35294, USA." } }, { "@type": "Person", "name": "Tamer M Gamal El-Din", "url": "https://questionsmedicales.fr/author/Tamer%20M%20Gamal%20El-Din", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, University of Washington, Seattle, WA, United States." } }, { "@type": "Person", "name": "Christopher L-H Huang", "url": "https://questionsmedicales.fr/author/Christopher%20L-H%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Hopkins Building, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Factors associated with the intention to donate blood in patients of a hospital in Peru].", "datePublished": "2024-10-02", "url": "https://questionsmedicales.fr/article/39355957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "Trends and geographical variation in mortality from coronary disease in Peru.", "datePublished": "2022-09-06", "url": "https://questionsmedicales.fr/article/36067204", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0273949" } }, { "@type": "ScholarlyArticle", "name": "Knowledge of dementia and Alzheimer's disease among healthcare professionals in Peru.", "datePublished": "2024-09-28", "url": "https://questionsmedicales.fr/article/39341209", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0044-1790576" } }, { "@type": "ScholarlyArticle", "name": "Ethnic inequalities in coverage and use of women's cancer screening in Peru.", "datePublished": "2024-07-24", "url": "https://questionsmedicales.fr/article/39048988", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12905-024-03225-6" } }, { "@type": "ScholarlyArticle", "name": "[Identification and sensitization to environmental fungal spores in Lima City, Peru].", "datePublished": "2024-02-01", "url": "https://questionsmedicales.fr/article/38683099", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.29262/ram.v71i1.1320" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Utilisations thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D045506" }, { "@type": "ListItem", "position": 5, "name": "Agents cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002317" }, { "@type": "ListItem", "position": 6, "name": "Bloqueurs de canaux sodiques", "item": "https://questionsmedicales.fr/mesh/D026941" }, { "@type": "ListItem", "position": 7, "name": "Bloqueurs de canaux sodiques voltage-dépendants", "item": "https://questionsmedicales.fr/mesh/D061567" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Bloqueurs de canaux sodiques voltage-dépendants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Comment diagnostiquer une intoxication aux bloqueurs de canaux sodiques ?\nQuels tests sont utilisés pour évaluer l'effet des bloqueurs ?\nQuels symptômes indiquent une surdose de bloqueurs ?\nComment différencier les types de bloqueurs de canaux ?\nQuels antécédents médicaux sont pertinents pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Peru&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quels sont les symptômes d'une intoxication aiguë ?\nComment se manifestent les effets secondaires des bloqueurs ?\nQuels signes indiquent une réaction allergique ?\nLes bloqueurs affectent-ils la respiration ?\nQuels symptômes neurologiques peuvent apparaître ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Peru&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Comment prévenir les effets indésirables des bloqueurs ?\nQuelles précautions doivent être prises avant la prescription ?\nLes patients doivent-ils être informés des risques ?\nComment éviter les interactions médicamenteuses ?\nQuelles sont les recommandations pour les patients à risque ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Peru&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quel est le traitement d'une surdose de bloqueurs ?\nComment gérer les effets secondaires des bloqueurs ?\nQuels médicaments peuvent interagir avec les bloqueurs ?\nLes bloqueurs sont-ils utilisés en anesthésie ?\nQuelle est l'importance de la surveillance pendant le traitement ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Peru&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quelles complications peuvent survenir avec les bloqueurs ?\nComment les complications sont-elles gérées ?\nLes complications sont-elles fréquentes ?\nQuels facteurs augmentent le risque de complications ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Peru&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quels sont les principaux facteurs de risque ?\nComment l'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'usage de drogues illicites est-il un facteur de risque ?\nLes maladies neurologiques augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Peru&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux bloqueurs de canaux sodiques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'historique médical, les symptômes cliniques et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'effet des bloqueurs ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des électrocardiogrammes et des tests de conduction nerveuse peuvent être utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose de bloqueurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des convulsions, une arythmie cardiaque et une dépression respiratoire peuvent survenir." } }, { "@type": "Question", "name": "Comment différencier les types de bloqueurs de canaux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse des effets cliniques et des mécanismes d'action aide à les différencier." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont pertinents pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de maladies cardiaques ou neurologiques sont cruciaux pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des vertiges, des nausées, des troubles de la vision et des convulsions." } }, { "@type": "Question", "name": "Comment se manifestent les effets secondaires des bloqueurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des étourdissements, des maux de tête et des troubles de la coordination." } }, { "@type": "Question", "name": "Quels signes indiquent une réaction allergique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, des démangeaisons et un gonflement peuvent signaler une allergie." } }, { "@type": "Question", "name": "Les bloqueurs affectent-ils la respiration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent entraîner une dépression respiratoire dans les cas graves." } }, { "@type": "Question", "name": "Quels symptômes neurologiques peuvent apparaître ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des convulsions, des troubles de la conscience et des paralysies peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables des bloqueurs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une prescription appropriée et une éducation du patient sont essentielles pour prévenir les effets indésirables." } }, { "@type": "Question", "name": "Quelles précautions doivent être prises avant la prescription ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer les antécédents médicaux et les allergies du patient est crucial avant la prescription." } }, { "@type": "Question", "name": "Les patients doivent-ils être informés des risques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients des risques et des signes d'intoxication est essentiel." } }, { "@type": "Question", "name": "Comment éviter les interactions médicamenteuses ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un examen minutieux des médicaments prescrits et des antécédents est nécessaire pour éviter les interactions." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les patients à risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les patients à risque doivent être suivis de près et éduqués sur les signes d'alerte." } }, { "@type": "Question", "name": "Quel est le traitement d'une surdose de bloqueurs ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des soins de soutien, l'administration de charbon actif et des antidotes si disponibles." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires des bloqueurs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique l'ajustement de la dose ou le changement de médicament selon les symptômes." } }, { "@type": "Question", "name": "Quels médicaments peuvent interagir avec les bloqueurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les antidépresseurs et les anesthésiques peuvent interagir." } }, { "@type": "Question", "name": "Les bloqueurs sont-ils utilisés en anesthésie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains bloqueurs de canaux sodiques sont utilisés pour induire une anesthésie locale." } }, { "@type": "Question", "name": "Quelle est l'importance de la surveillance pendant le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance est cruciale pour détecter les effets indésirables et ajuster le traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les bloqueurs ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des arythmies, des convulsions et des défaillances respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite une intervention rapide et un traitement symptomatique." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout en cas de surdose ou d'interactions." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge avancé, les maladies cardiaques et l'utilisation concomitante d'autres médicaments augmentent le risque." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance attentive et une éducation adéquate peuvent aider à prévenir certaines complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de maladies cardiaques, l'âge et l'utilisation d'autres médicaments sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées ont un risque accru de complications en raison de la polypharmacie et de la fragilité." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies cardiaques ou neurologiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'usage de drogues illicites est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage de certaines drogues peut interagir avec les bloqueurs et augmenter le risque d'effets indésirables." } }, { "@type": "Question", "name": "Les maladies neurologiques augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients ayant des maladies neurologiques peuvent être plus sensibles aux effets des bloqueurs." } } ] } ] }

Sources (911 au total)

[Factors associated with the intention to donate blood in patients of a hospital in Peru].

Research on factors that modify the intention to donate blood voluntarily in the general population in Peru is scarce, and most of it are focused on health science personnel. The aim of the present st... A prospective unpaired study of cases (n=185) and controls (n=185) was designed. A case was defined as a patient who responded "if I would voluntarily donate blood in the future" to the initial filter... In the multivariate analysis, male sex (ORa=1.37), having a high monthly income (ORa=1.26), professing the catholic religion (ORa=5.27), having a higher score in the knowledge questionnaire (ORa=1.04)... Several factors associated with the intention to donate blood are identified, most of which were similar to previous studies. It is highlighted that a high level of knowledge, as well as previous dona...

Trends and geographical variation in mortality from coronary disease in Peru.

Coronary disease (CD) is the main cause of mortality worldwide. Data about trends and geographical variation in CD mortality is available in some American countries. This information varies among coun... To describe the trend and geographical variation of coronary disease (CD) mortality in Peru, 2005-2017.... Analysis of secondary data of the Peruvian Ministry of Health's registry of deaths. We analyzed CD mortality. We described the absolute and relative frequency of deaths and age-standardized mortality ... There were 64,721 CD deaths between 2005 and 2017 (4.12% among all deaths). The absolute frequency of CD deaths was 5,665 and 6,565 in 2005 and 2017, respectively. CD mortality was more frequent in me... CD mortality has increased in Peru. Mortality was higher in men and older adults, and it varied among departments. More political efforts are needed to reduce these trends....

Knowledge of dementia and Alzheimer's disease among healthcare professionals in Peru.

Primary care physicians and other healthcare providers report feeling unprepared to treat persons with dementia (PWD), especially in developing countries OBJECTIVE: We aimed to assess the knowledge of... We conducted an in-person and virtual survey of healthcare professionals trained in Peru throughout the year 2020. The survey was developed based on a previously published one and reviewed by an exper... Out of 804 surveys, we excluded 56 due to incomplete data. A total of 41.6% of respondents were doctors and 21.8%, nurses. One fifth of participants did not recognize AD as a cause of dementia and ove... There is a low level of knowledge of dementia and AD among health professionals in Peru, which worsens outside of Lima. Pernicious ideas, such as senile dementia, are still significantly present among...

Ethnic inequalities in coverage and use of women's cancer screening in Peru.

This study aimed to assess ethnic inequalities in the coverage and utilization of cancer screening services among women in Peru.... Data from the 2017-2023 Demographic and Family Health Survey in Peru were analyzed to evaluate ethnic disparities in screening coverage for breast and cervical cancer, including clinical breast examin... The study included 70,454 women aged 30-69. Among women aged 40-69, 48.31% underwent CBE, 84.06% received PST, and 41.69% underwent mammography. It was found inequalities in coverage for any cancer sc... Ethnic inequalities affect breast and cervical cancer screening coverage across regions in Peru. In Quechua, Aymara, and Afro-Peruvian women the uptake of mammography, CBE, and PST was less frequently...

[Identification and sensitization to environmental fungal spores in Lima City, Peru].

To identify and registry the most important fungal spores trapped in our aerobiology station, as well as to report the prevalence of skin sensitization to these allergens.... The pollen counts were made according to standardized technique with a Burkard seven days spore trap, following the American Academy of Allergy, Asthma and Immunology (AAAAI) through National Allergy ... We identified spores of... The inhabitants of the south-western area of the urban city of Lima are exposed to different fungal spores with allergenic potential, with a higher concentration being identified during the summer/aut...

Characteristics of theses for physician graduation: a cross-sectional study in Peru.

Research in Peru presents several barriers that impede its development and that also affects the theses to graduate as physician. Our objective was to characterize the theses for obtaining a medical d... An observational and descriptive study evaluating the theses for obtaining a medical degree of 2019, evaluated in January 2022 from 22 universities that are full members of the Peruvian Association of... A total of 1838 theses were evaluated. Most of the theses were written by a single student (66.16%). The most common study design was the descriptive cross-sectional type (42.33%). We found that 53.86... Two-thirds of the theses conducted by medical students in Peru are descriptive studies. Half respond to national research priorities. Four out of ten theses were approved by an institutional research ...

HIV treatment cascade in regions of Peru with the highest HIV prevalence.

To describe the HIV treatment cascade and care continuum in regions of highest HIV prevalence in Peru.... An observational longitudinal study was carried out in 14 tertiary hospitals in Peru. These are the main hospitals that administer antiretroviral treatment (ART) in the regions that represent approxim... A total of 2119 people living with HIV (PLHIV) were identified in the selected health facilities (mean age = 35.26 years, 78% male). 97.25% [1845/1897; 95% confidence interval (CI): 96.4-97.9%] of the... Further analysis and improvements in the definition of indicators are required to achieve conclusive results; however, these data will give us a general understanding of the progress of Peruvian healt...

Association between blood glucose levels and autonomic symptoms in Peru.

To determine whether there is an association between high blood glucose levels and having autonomic symptoms among adults aged 30-69 years.... A population-based cross-sectional study was conducted. The presence of autonomic symptoms was defined as the positive response to any item of the Survey of Autonomic Symptoms (SAS). Blood glucose lev... A total of 1607 subjects, mean age 48.2 (SD: 10.6) and 810 (49.7 %) women, were included. T2D was associated with higher prevalence of erectile dysfunction (PR = 3.00; 95 % CI: 1.78-5.02) and dryness ... Erectile dysfunction and dry mouth and eyes are the more common autonomic symptoms associated with T2D. Our results suggest a periodic evaluation of sexual function and eye humidity among T2D patients...

Disaster Preparedness and Hospital Safety in State Hospitals in Lima (Peru).

Peru's health infrastructures, particularly hospitals, are exposed to disaster threats of different natures. Traditionally, earthquakes have been the main disaster in terms of physical and structural ... The aim of this study was to analyze the Hospital Safety Index (HSI) in hospitals in Lima (Peru).... This was a cross-sectional observational study of 18 state-run hospitals that met the inclusion criteria; open access data were collected for the indicators proposed by the Pan American Health Organiz... The average bed occupancy rate was 90%, the average age was 70 years, on average had one bed per 25,126 inhabitants, and HSI average score was 0.36 with a vulnerability of 0.63. No association was fou... Most of the hospitals were considered Category C in earthquake and disaster safety, and only one hospital was Category A. The hospital situation needs to be clarified, and the specific deficiencies of...